-
Online prescription drugs are facing a policy vacuum, who will protect consumers' drug safety?
Time of Update: 2021-12-27
Another platform will jump to the interface for issuing electronic prescriptions after purchasing drugs, and online doctors will ask patients for consultation and prescribe prescriptions .
-
The Tibet Autonomous Region Medical Insurance Bureau notified the national centralized procurement of drugs and procurement related issues
Time of Update: 2021-12-27
The details are as follows: All relevant regional (city) medical security bureaus: Since the national organization of centralized drug procurement, individual medical institutions in our district have severely decoupled from reporting and procurement, and there is even the problem of zero completion ratio of agreed procurement, which seriously affects our country.
-
There are many stories behind the development of my country’s first approved new crown therapeutic drug: the tripartite cooperation took less than 20 months
Time of Update: 2021-12-27
The new crown neutralizing antibody drug approved this time was jointly developed by Tsinghua University, Shenzhen Third People's Hospital and Tengsheng Bo Pharmaceutical .
-
TOP20 brands in the health care products market fell three times in a row and fell below 7 billion!
Time of Update: 2021-12-27
Figure 2: Annual sales of Glucosamine / Glucosamine Chondroitin Calcium / Chondroitin Calcium (Unit: 100 million yuan) Source: Mi Nei. com China's urban physical pharmacies terminal layout in the past three years, Glucosamine / Glucosamine Chondroitin Calcium / Chondroitin The overall sales scale of calcium products is steadily increasing, which is closely related to the aging of the population.
-
The number of new clinical trials launched globally in November decreased month-on-month
Time of Update: 2021-12-25
(Data source: US Clinicaltrial Database) In November of this year, the total number of newly launched clinical trials led by corporate capital was 835, a decrease of 2.
-
Reform of medical insurance payment methods promotes a win-win situation for the three parties
Time of Update: 2021-12-25
According to the National Medical Insurance Administration, under the new payment model, medical institutions in pilot areas actively control costs, reduce unnecessary diagnosis and treatment, medicine and consumable items, and improve the level of refined management.
-
Approximately 70,000 medical devices have been coded in Guangdong Province, a summary of the UDI implementation process in many places
Time of Update: 2021-12-25
The Sichuan Provincial Food and Drug Administration has made it clear in promoting the UDI work node that it will complete all three types of medical device product codes, data uploading and maintenance from September to November 2021 .
-
The results of the 2021 medical insurance negotiations are released, and CAR-T therapy is missed for the first time. Where is the road to protection in the future?
Time of Update: 2021-12-25
Helping with multi-level medical protection, Meixin Health allows more patients to use good medicine Meixin Health's action to improve the availability of CAR-T therapy drugs stems from the company's vision of building a company where everyone is guaranteed and the whole family enjoys health, so as to allow better quality medical and health services to benefit every family and help build a happier future Society .
-
Insight into the direction of medical insurance access from the eight points of view in the new catalogue!
Time of Update: 2021-12-25
Among the 67 newly-added negotiation catalog products, the perfluoropropane human albumin microspheres for injection and clotrimazole vaginal expansion suppositories were entered into the medical insurance list without entering the formal review .
-
Chia Tai Tianqing's innovative drugs explode this year, 17 new class 1 drugs hit
Time of Update: 2021-12-25
Source: CDE official website On December 14, the clinical application for TQH3910 tablets submitted by Chia Tai Tianqing as a new drug category 1 was accepted by the CDE, with the acceptance numbers CXHL2101750 and CXHL2101751 .
-
Sequential booster immunization against mutant strains to improve vaccination strategies is imperative
Time of Update: 2021-12-24
” Sun Xiaodong believes that boosting immunization to induce high-titer neutralizing antibodies is theoretically Speaking, it has a certain protective effect on mutant strains, so don't worry too much .
-
Implementation of the record management of traditional Chinese medicine formula particles "emerge into a butterfly"
Time of Update: 2021-12-08
On October 29, the Comprehensive and Planning Finance Department of the State Food and Drug Administration issued a clear notice that the Chinese medicine formula granule varieties will be subject to
-
Shandong: The rules for the management of traditional Chinese medicine formula granules set a five-year validity period
Time of Update: 2021-12-08
The "Administrative Rules" clarified that the traditional Chinese medicine formula granules produced, sold and used in Shandong Province should meet the national drug standards or the provincial standard of Chinese medicine formula granules .
-
A group of medical institutions were severely punished!
Time of Update: 2021-12-08
Recently, according to a report from the State Administration of Market Supervision, Hangzhou Huashi Hospital was fined RMB 849,000 for publishing false and illegal advertisements in its business activities, which aroused the attention of the industry .
-
The problem of "high-quality, difficult-to-price" is becoming more and more serious
Time of Update: 2021-12-08
At the same time, due to the lag in the construction of industrial standardization, the problem of authentic Chinese medicinal materials "high-quality, hard-to-price" has become increasingly prominent .
-
Huahai broke out! FDA warning letter closed to win 5 blockbuster varieties
Time of Update: 2021-12-07
Recently, Huahai Pharmaceuticals announced heavy news: the southern Sichuan API base warning has been lifted, and sales in the US market are expected to resume .
-
Coron is full of firepower!
Time of Update: 2021-12-07
A few days ago, Kelun Pharmaceutical released the third quarter report, the company's performance has resumed growth, and innovation results have gradually emerged . According to data from Minaiwan
-
AstraZeneca County business adjustment!
Time of Update: 2021-12-07
On November 12, Johnson & Johnson announced that it plans to split and reorganize the three existing businesses: the merger of the pharmaceutical and medical device businesses, the independent consumer health care business, and the establishment of two listed companies .
-
Merck meets its rivals!
Time of Update: 2021-12-07
com, the global sales of posaconazole in 2020 will exceed US$300 million, and the terminal of Chinese public medical institutions will increase by more than 90% year-on-year in 2021H1 .
The sales of terminal posaconazole in public medical institutions in China (unit: 100 million yuan) Source: Minet.
-
Behind the tens of billions acquisition: a face-lifting needle stirs up the beauty of medicine
Time of Update: 2021-12-07
5% of 900kDa effective protein), high effect (the same effect as Botox, which has been approved for marketing and represents the highest level of botulinum toxin), and high quality (the product has a uniform and stable effect) With the “three high effects” of Le Tibao, Le Tibao quickly increased its volume once it was officially sold .
